Free Trial

Exelon (EXC) Stock Forecast & Price Target

Exelon logo
$43.42 -0.77 (-1.73%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Exelon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
5
Buy
4

Based on 10 Wall Street analysts who have issued ratings for Exelon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 10 analysts, 1 has given a sell rating, 5 have given a hold rating, and 4 have given a buy rating for EXC.

Consensus Price Target

$47.30
8.93% Upside
According to the 10 analysts' twelve-month price targets for Exelon, the average price target is $47.30. The highest price target for EXC is $51.00, while the lowest price target for EXC is $39.00. The average price target represents a forecasted upside of 8.93% from the current price of $43.42.
Get the Latest News and Ratings for EXC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Exelon and its competitors.

Sign Up

EXC Analyst Ratings Over Time

TypeCurrent Forecast
5/22/24 to 5/22/25
1 Month Ago
4/22/24 to 4/22/25
3 Months Ago
2/22/24 to 2/21/25
1 Year Ago
5/23/23 to 5/22/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
4 Hold rating(s)
10 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$47.30$45.63$43.38$38.83
Forecasted Upside8.93% Upside-3.68% Downside-0.03% Downside2.46% Upside
Consensus Rating
Hold
Hold
Moderate Buy
Hold

EXC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EXC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Exelon Stock vs. The Competition

TypeExelonUtilities CompaniesS&P 500
Consensus Rating Score
2.30
2.51
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside7.04% Upside19.61% Upside15.68% Upside
News Sentiment Rating
Positive News

See Recent EXC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/22/2025Morgan Stanley
3 of 5 stars
David Arcaro
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$49.00 ➝ $48.00+8.62%
5/14/2025KeyCorp
3 of 5 stars
Sophie Karp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeSector Weight ➝ Underweight$39.00-9.24%
5/2/2025Wells Fargo & Company
3 of 5 stars
Neil Kalton
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$46.00 ➝ $50.00+7.57%
5/2/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Pourreza
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$47.00 ➝ $50.00+7.93%
5/2/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Chopra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetIn-Line ➝ In-Line$48.00 ➝ $51.00+9.91%
4/28/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
James Thalacker
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$46.00 ➝ $50.00+7.51%
3/21/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Daniel Ford
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$45.00 ➝ $47.00+6.52%
2/25/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Nicholas Campanella
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$42.00 ➝ $48.00+10.73%
2/13/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Andrew Weisel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Perform ➝ Sector Perform$42.00 ➝ $44.00+2.00%
9/19/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$46.00+17.08%
1/19/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$38.00 ➝ $36.00+2.53%
1/10/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$36.00 ➝ $39.00+7.03%
1/8/2024Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Storozynski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
12/19/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform ➝ Sector Perform$45.00 ➝ $38.00+9.16%
12/18/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$41.00+18.09%
6/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$39.00-3.32%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:59 PM ET.


Should I Buy Exelon Stock? EXC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 21, 2025. Please send any questions or comments about these Exelon pros and cons to contact@marketbeat.com.

Exelon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Exelon Co.:

  • The current stock price is around $44, which is relatively stable and shows potential for growth based on recent analyst upgrades.
  • Exelon Co. reported a quarterly earnings per share of $0.92, exceeding analysts' expectations, indicating strong financial performance.
  • The company has a solid revenue growth of 11.1% compared to the same quarter last year, reflecting its ability to increase sales effectively.
  • Exelon Co. has a dividend yield of approximately 3.62%, providing a steady income stream for investors through its quarterly dividend payments.
  • Analysts have a consensus rating of "Hold" with a price target of $47.30, suggesting that the stock is viewed positively with room for appreciation.

Exelon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Exelon Co. for these reasons:

  • Exelon Co. has a debt-to-equity ratio of 1.61, which indicates a higher level of debt compared to equity, potentially increasing financial risk.
  • One analyst has rated the stock with a sell rating, suggesting some market skepticism about its future performance.
  • The company has a quick ratio of 0.78, which is below 1, indicating potential liquidity issues in meeting short-term obligations.
  • Recent analyst ratings have shown mixed sentiments, with some firms downgrading their ratings, which may create uncertainty among investors.
  • The stock has experienced fluctuations, with a 52-week high of $48.11 and a low of $34.01, indicating volatility that could deter risk-averse investors.

EXC Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Exelon is $47.30, with a high forecast of $51.00 and a low forecast of $39.00.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exelon in the last year. There is currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXC, but not buy additional shares or sell existing shares.

According to analysts, Exelon's stock has a predicted upside of 8.93% based on their 12-month stock forecasts.

Over the previous 90 days, Exelon's stock had 1 downgrade by analysts.

Exelon has been rated by research analysts at Barclays, BMO Capital Markets, Evercore ISI, Guggenheim, KeyCorp, Morgan Stanley, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Exelon less than other "utilities" companies. The consensus rating score for Exelon is 2.30 while the average consensus rating score for "utilities" companies is 2.50. Learn more on how EXC compares to other companies.


This page (NASDAQ:EXC) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners